Pharmaceutical Partners of Canada

Pharmaceutical Partners of Canada (PPC) was a leading Canadian pharmaceutical company specializing in the development and marketing of generic injectable medicines for the hospital market. The company focused on providing high-quality, cost-effective alternatives to brand-name injectables in critical therapeutic areas such as oncology, anesthesia, and anti-infectives. PPC became a vital supplier to the Canadian healthcare system, ensuring the availability of essential multi-source injectable products. In 2008, the company was acquired by Fresenius Kabi as part of its acquisition of APP Pharmaceuticals. Today, its operations are fully integrated into Fresenius Kabi Canada, continuing its mission to supply hospitals with critical care and infusion therapy products.